VVS Distribution Ltd
Registered name: VVS DISTRIBUTION LTD
Part of G Square Healthcare Private Equity LLP groupVVS Distribution Ltd made £7.1m revenue and £678k profit in the year to 31 Mar 2025.
VVS Distribution Ltd’s revenue grew 6% to £7.1m in the year to 31 Mar 2025, with £678k profit and 22 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Leeds; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Leeds
- Age
- 5 yrs · since 2021
- Type
- Private Limited Company
Key figures
Financial history
| Year to | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £5.8m | £6.7m | £7.1m |
| Cost of sales | −£4m | −£4.5m | −£4.7m |
| Gross profit | £1.7m | £2.2m | £2.4m |
| Operating profit | £516k | £567k | £774k |
| Profit before tax | £383k | £435k | £678k |
| Profit after tax | £383k | £435k | £678k |
| Profit (best available) | £383k | £435k | £678k |
| Employees (average) | 15 | 20 | 22 |
| Ratios | |||
| Profit margin | 6.6% | 6.5% | 9.5% |
| Gross margin | 29.9% | 32.7% | 34% |
| Revenue per employee | £385k | £335k | £324k |
| Profit per employee | £25.6k | £21.7k | £30.8k |
| Growth (year on year) | |||
| Revenue growth | — | ▲16% | ▲6.4% |
| Profit growth | — | ▲13.4% | ▲56% |
| Headcount growth | — | ▲33.3% | ▲10% |
| Balance sheet — indirect signals, not revenue | |||
| Net assets | — | — | — |
| Source | Accounts · bulk data Apr 2025 | Accounts · bulk data Apr 2025 | Accounts · bulk data Jan 2026 |
How the business works
- Profit margin
- 9.5%
- Profit ÷ revenue.
- Gross margin
- 34%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £324k
- Revenue ÷ average employees.
- Profit per employee
- £30.8k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- ▲10%
- Now 22
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- G Square Healthcare Private Equity LLPultimate parent75–100%
- G Square Managing Member Limited75–100%
- G Square Capital (GP) II LLP25–50%
- P2U Holdings Limited75–100%
- Pharmacy2u Limited75–100%
- VVS Distribution Ltdthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (7)
- Expert Health LimitedRev. £26.3m · Profit £1.4m
- Chemd Holdings LimitedFigures not disclosed
- Medicines Management Solutions LtdFigures not disclosed
- Metabolic Healthcare LtdFigures not disclosed
- Prescription Point LtdFigures not disclosed
- Private Meds LimitedFigures not disclosed
- The Pharmpet Co LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from accounts for the year to 31 Mar 2025 (profit £678k), from the Companies House accounts bulk data published Jan 2026. Spotted an error? Request a correction.
Updated from Companies House on 16 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.